相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular Delivery of Bioorthogorral Pretargeting Therapeutics in PSMA-Positive Prostate Cancer
Sudath Hapuarachchige et al.
MOLECULAR PHARMACEUTICS (2020)
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer
Kazuya Maeda et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-advanced colorectal cancer
Maresa McGettigan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen
Sangeeta Ray Banerjee et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy
Yang Du et al.
NANO LETTERS (2019)
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
Prathap Kumar Mahalingaiah et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
Thomas Langbein et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Dual Radionuclide Theranostic Pretargeting
Outi Keinanen et al.
MOLECULAR PHARMACEUTICS (2019)
Peptide nucleic acid (PNA) and its applications in chemical biology, diagnostics, and therapeutics
Jacques Saarbach et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Recent Advances in Bioorthogonal Click Chemistry for Efficient Synthesis of Radiotracers and Radiopharmaceuticals
Sajid Mushtaq et al.
MOLECULES (2019)
Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects
Meinan Yao et al.
THERANOSTICS (2019)
Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy
Xiaoming Hu et al.
THERANOSTICS (2019)
Targeted Radioimmunotherapy and Theranostics with Alpha Emitters
Neeta Pandit-Taskar
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES (2019)
Deep-tissue optical imaging of near cellular-sized features
Xiangnan Dang et al.
SCIENTIFIC REPORTS (2019)
Rod-shape MSN@MoS2 Nanoplatform for FL/MSOT/CT Imaging-Guided Photothermal and Photodynamic Therapy
Lifang Yang et al.
THERANOSTICS (2019)
Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicines
E. Johanna L. Steen et al.
BIOMATERIALS (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
Sara Bravaccini et al.
SCIENTIFIC REPORTS (2018)
A Supramolecular Approach for Liver Radioembolization
Silvia J. Spa et al.
THERANOSTICS (2018)
Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy
Fotios Mpekris et al.
JOURNAL OF CONTROLLED RELEASE (2017)
A PSMA-targeted theranostic agent for photodynamic therapy
Ying Chen et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models
Benjamin B. Kasten et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools
Zora Novakova et al.
PROSTATE (2017)
TheranosticsTheranostics in nuclear medicine practice
Anna Yordanova et al.
ONCOTARGETS AND THERAPY (2017)
Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody
Chao Wang et al.
ONCOTARGET (2017)
18F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels Alder Click Chemistry
Jan-Philip Meyer et al.
BIOCONJUGATE CHEMISTRY (2016)
PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
Zhihang Chen et al.
BIOMATERIALS (2016)
Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors
Hadis Honarvar et al.
THERANOSTICS (2016)
A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer
Pierre Adumeau et al.
THERANOSTICS (2016)
Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models
Sudath Hapuarachchige et al.
SCIENTIFIC REPORTS (2016)
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Maria Luque-Cabal et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2016)
A Novel 111In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
Kristell L. S. Chatalic et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
Thomas Ebenhan et al.
MOLECULES (2015)
Advances in optical imaging for pharmacological studies
Alicia Arranz et al.
FRONTIERS IN PHARMACOLOGY (2015)
Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer
Darren M. C. Poon et al.
PROSTATE INTERNATIONAL (2015)
Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics
Sudath Hapuarachchige et al.
BIOMATERIALS (2014)
Evaluation of simultaneous 201Tl/99mTc dual-isotope cardiac SPECT imaging with model-based crosstalk compensation using canine studies
Y. Du et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2014)
Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry
Floor C. J. van de Watering et al.
FRONTIERS IN MEDICINE (2014)
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
Ronnie C. Mease et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Novel Therapies for the Treatment of Advanced Prostate Cancer
J. M. Clarke et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2013)
Delivery of molecular and cellular medicine to solid tumors
Rakesh K. Jain
ADVANCED DRUG DELIVERY REVIEWS (2012)
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer
Sandhya Girish et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Theranostic imaging of cancer
Marie-France Penet et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Emerging novel therapies for advanced prostate cancer
Susanne Osanto et al.
THERAPEUTIC ADVANCES IN UROLOGY (2012)
Targeting of drugs and nanoparticles to tumors
Erkki Ruoslahti et al.
JOURNAL OF CELL BIOLOGY (2010)
Resistance to Trastuzumab in Breast Cancer
Paula R. Pohlmann et al.
CLINICAL CANCER RESEARCH (2009)
PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach
Wenlian Zhu et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Tissue-like phantoms for near-infrared fluorescence imaging system assessment and the training of surgeons
AM De Grand et al.
JOURNAL OF BIOMEDICAL OPTICS (2006)
分享论文
